Clinical Trials Logo

Clinical Trial Summary

Reiki is an energy-based healing therapy using light touch. Manual therapy is a technique using light effleurage. These complimentary healing services are utilized to promote relaxation, sleep, improve emotions, and decrease pain; however, more research is required since sample sizes in the literature were small, subjects were generally healthy (not hospitalized), and subjects had multiple medical backgrounds. Only 1 study focused on cardiac surgery patients. We aim to learn if Reiki and manual therapy enhances postoperative clinical outcomes for patients after first time coronary artery bypass graft (CABG) and/or cardiac valve surgery. A randomized, controlled non-blinded study will enroll a sample of a minimum of 272 patient (136 per group), based on a power analysis using the primary outcome. The intervention group will receive usual care plus Reiki and manual therapy, with Reiki delivered first. Total therapies time is 20 minutes. Reiki and manual therapy will be delivered for 3 consecutive days beginning on the day after endotracheal tube removal. The usual care group will receive 20 minutes of uninterrupted rest, which is part of usual postoperative care. Outcomes are depression, anxiety, pain, night time sleep, new onset atrial fibrillation, hospital length of stay, all-cause 30-day hospital readmissions, narcotic drug burden and post-operative complications.


Clinical Trial Description

Background: Reiki is an energy-based healing therapy using light touch. Manual therapy is a technique using light effleurage. These complimentary healing services are utilized to promote relaxation, sleep, improve emotions, and decrease pain. After reviewing the Reiki research literature, more research is required since sample sizes were small, subjects were generally healthy (not hospitalized), and subjects had multiple medical backgrounds. Only 1 study focused on cardiac surgery patients. In the current research study, we aim to learn if Reiki and manual therapy enhances postoperative clinical outcomes for patients after first time coronary artery bypass graft (CABG) and/or cardiac valve surgery. Design and Methods: A randomized, controlled non-blinded study will be used. The sample size (272 total; 136 per group) was based on a power analysis using the primary outcome. The intervention group will receive usual care plus Reiki and manual therapy, with Reiki being delivered first. Hand placements include: head, chest, shoulders, hands, knees, and feet for 15 minutes. Manual therapy will consist of light effleurage to the head and feet for 5 minutes. Total therapies time is 20 minutes. Reiki and manual therapy will be delivered for 3 consecutive days beginning on the day after endotracheal tube removal. The usual care group will receive 20 minutes of uninterrupted rest, which is part of usual postoperative care. There will not be a sham-treatment group, based on previous research findings. Outcome Measures: depression and anxiety (Brief Symptom Inventory, 12-item self-administered tool); pain (self-reported and recorded in electronic health record by staff nurses as part of usual care -- 0 [no pain] - 10 [worst pain] scale), highest (worst) and lowest (least) pain in the past 24 hours will be assessed; night time sleep (Richards-Campbell Sleep Questionnaire; 5 item self-administered tool)-to be measured at baseline and after the last Reiki/manual therapy treatment or 3 days of usual care; hospital length of stay, all-cause 30-day hospital readmissions (data top be retrieved from a billing database), narcotic drug burden (mean dose) use on postoperative days 3 and 4 (retrieved from electronic medical records), patient characteristics, medical history, surgical procedure, new onset atrial fibrillation and other post-operative complications (retrieved from the Institutional Review Board--approved Cardiothoracic Surgery database). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05853250
Study type Interventional
Source The Cleveland Clinic
Contact
Status Completed
Phase N/A
Start date June 26, 2017
Completion date February 5, 2020

See also
  Status Clinical Trial Phase
Completed NCT00328315 - Cardiac SPECT With Rotating Slant Hole Collimator
Recruiting NCT02257710 - BIOFLOW-III UK Satellite Registry Orsiro Stent System N/A
Active, not recruiting NCT02273648 - BIOTRONIK - BIOFLOW-III Registry French Satellite N/A
Recruiting NCT01157455 - A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Phase 4
Completed NCT02028728 - BIOFLOW III Satellite-Italy Orsiro Stent System N/A
Completed NCT02813473 - SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease
Recruiting NCT02635230 - What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Completed NCT01116882 - Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings N/A
Completed NCT00920283 - COMPETE: A Clinical Evaluation of Chrono Carbostent Carbofilmâ„¢ Coated Stent N/A
Completed NCT01700075 - Physical and Chemical Study of Atherosclerosis Mechanisms Phase 4
Completed NCT00607217 - The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases Phase 2/Phase 3
Completed NCT00607178 - The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases Phase 2/Phase 3
Not yet recruiting NCT05486780 - The Effect of Digital Window on Day and Night Perception Status and Sleep Quality in Intensive Care Patients N/A
Terminated NCT01665248 - Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina N/A
Terminated NCT01612819 - DXR Stent(Previous Cilotax) Implantation Registry N/A
Active, not recruiting NCT01226355 - NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System N/A
Recruiting NCT02247492 - BIOFLOW-III VIP Russia Registry Orsiro Stent System